Expression of p63 and p73 in retinoblastoma: A clinicopathological correlation study

Experimental Eye Research

Volumn 87, Issue 4, 2008, Pages 312-318

  Adithi, Mohan ^a   Nalini, Venkatesan ^a   Kandalam, Mallikarjuna ^a   Krishnakumar, Subramanian ^a  

^a VISION RESEARCH FOUNDATION   (India)

Author keywords

differentiation; immunohistochemistry; invasion; p63; p73; retinoblastoma

Indexed keywords

PARAFFIN; PROTEIN P63; PROTEIN P73;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECURRENCE RISK; RETINOBLASTOMA;

ADOLESCENT; ADULT; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; EYE PROTEINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; MALE; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; RETINA; RETINAL NEOPLASMS; RETINOBLASTOMA; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 52049085323     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2008.06.010     Document Type: Article

References (28)

1. Barbareschi M., Pecciarini L., Cangi M.G., Macri E., Rizzo A., Viale G., and Doglioni C. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am. J. Surg. Pathol. 25 (2001) 1054-1060
2. Crook T., Nicholls J.M., Brooks L., O'Nions J., and Allday M.J. High level expression of del-N-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC). Oncogene 19 (2000) 3439-3444
3. Di Como C.J., Urist M.J., Babayan I., et al. p63 expression profiles in human normal and tumor tissues. Clin. Cancer Res. 8 (2002) 494-501
4. Glickman J.N., Yang A., Shahsafaei A., McKeon F., and Odze R.D. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders. Hum. Pathol. 32 (2001) 1157-1165
5. Hibi K., Trink B., Patturanjan M., Westra W.H., Caballero O.L., Hill D.E., Ratovitski E.A., Jen J., and Sidransky D. AIS is an oncogene amplified in squamous cell carcinoma. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 5462-5467
6. Hollstein M., Shomer B., Greenblatt M., Soussi T., Hovig E., Montesano R., and Harris C.C. Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res. 24 (1996) 141-146
7. Hollstein M., Sidransky D., and Vogelstein C.C. p53 mutations in human cancers. Science 253 (1991) 49-53
8. Irwin M.S., and Kaelin W.G. p53 family update: p73 and p63 develop their own identities. Cell Growth Differ. 12 (2001) 337-349
9. Jost C., Marin M., and Kaelin W.J. p73 is a human p53-related protein that can induce apoptosis. Nature 389 (1997) 191-194
10. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J.-C., Valent A., Minty A., Chalon P., Lelias J.-M., Dumont X., Ferrara P., McKeon F., and Caput D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90 (1997) 809-819
11. Ko L.J., and Prives C. p53: puzzle and paradigm. Genes Dev. 10 (1996) 1054-1072
12. Lane D.P. Cancer. p53, guardian of the genome. Nature 358 (1992) 15-16
13. Laurie N.A., Donovan S.L., Shih C.S., Zhang J., Mills N., Fuller C., Teunisse A., Lam S., Ramos Y., Mohan A., Johnson D., Wilson M., Rodriguez-Galindo C., Quarto M., Francoz S., Mendrysa S.M., Guy R.K., Marine J.C., Jochemsen A.G., and Dyer M.A. Inactivation of the p53 pathway in retinoblastoma. Nature 444 (2006) 61-66
14. Levrero M., De Laurenzi V., Costanzo A., Sabatini S., Gong J., Wang J.Y.J., and Melino G. The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J. Cell Sci. 113 (2000) 1661-1670
15. Melino G., Lu X., Gasco M., Crook T., and Knight R.A. Functional regulation of p73 and p63: development and cancer. Trends Biochem. Sci. 28 (2003) 663-670
16. Mills A.A., Zheng B., Wang X., Vogel H., Roop D.R., and Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature (Lond.) 398 (1999) 708-713
17. Moll U.M., and Slade N. p63 and p73: roles in development and tumor formation. Mol. Cancer Res. 2 (2004) 371-386
18. Niyazi M., Ghazizadeh M., Konishi H., Kawanami O., Sugisaki Y., and Araki T. Expression of p73 and c-Abl proteins in human ovarian carcinomas. J. Nippon Med. Sch. 70 (2003) 234-242
19. Nylander K., Coates P.J., and Hall P.A. Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions. Int. J. Cancer 87 (2000) 368-372
20. Quade B.J., Yang A., Wang Y., et al. Expression of the p53 homologue p63 in early cervical neoplasia. Gynaecol. Oncol. 80 (2001) 24-29
21. Schmale H., and Bamberger C. A novel protein with strong homology to the tumor suppressor p53. Oncogene 15 (1997) 1363-1367
22. Sun X.F. p73 overexpression is a prognostic factor in patients with colorectal adenocarcinoma. Clin. Cancer Res. 8 (2002) 165-170
23. Tannapfel A., Wasner M., Krause K., Geissler F., Katalinic A., Hauss J., Mossner J., Engeland K., and Wittekind C. Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma. J. Natl. Cancer Inst. 91 (1999) 1154-1158
24. Uramoto H., Sugio K., Oyama T., Nakata S., Ono K Morita M., Funa K., and Yasumoto K. Expression of ΔNp73 predicts poor prognosis in lung cancer. Clin. Cancer Res. 10 (2004) 6905-6911
25. Yamaguchi K., Wu L., Caballero O.L., Hibi K., Trink B., Resto V., Cairns P., Okami K., Koch W.M., Sidransky D., and Jen J. Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma. Int. J. Cancer 86 (2000) 684-689
26. Yang A., Kaghad M., Wang Y., Gillett E., Fleming M.D., Dotsch V., Andrews N.C., Caput D., and McKeon F. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 2 (1998) 305-316
27. Yang A., Schweitzer R., Sun D., Kaghsad M., Walker N., Bronson R.T., Tabin C., Sharpe A., Caput D., Crum C., and McKeon F. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature (Lond.) 398 (1999) 714-718
28. Yang A., Walker N., Bronson R., Kaghad M., Oosterwegel M., Bonnin J., Vagner C., Bonnet H., Dikkes P., Sharpe A., McKeon F., and Caput D. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature (Lond.) 404 (2000) 99-103